Glassman Wealth Services continued to hold its stake in Walgreens Boots Alliance Inc. (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,880 shares of the pharmacy operator’s stock at the end of the second quarter. Glassman Wealth Services’ holdings in Walgreens Boots Alliance were worth $240,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. MCF Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. MCF Advisors LLC now owns 1,371 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 6 shares during the last quarter. First Citizens Bank & Trust Co. increased its stake in shares of Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock valued at $206,000 after buying an additional 21 shares during the last quarter. Atlanta Capital Group increased its stake in shares of Walgreens Boots Alliance by 1.1% in the second quarter. Atlanta Capital Group now owns 4,088 shares of the pharmacy operator’s stock valued at $340,000 after buying an additional 45 shares during the last quarter. Signaturefd LLC increased its stake in shares of Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock valued at $150,000 after buying an additional 48 shares during the last quarter. Finally, Rathbone Brothers plc increased its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Rathbone Brothers plc now owns 11,345 shares of the pharmacy operator’s stock valued at $945,000 after buying an additional 50 shares during the last quarter. 59.75% of the stock is owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.05% during trading on Tuesday, hitting $80.77. The company had a trading volume of 1,054,167 shares. The firm has a market capitalization of $87.42 billion, a P/E ratio of 27.91 and a beta of 1.01. The stock’s 50-day moving average is $81.62 and its 200 day moving average is $81.26. Walgreens Boots Alliance Inc. has a 52-week low of $71.50 and a 52-week high of $95.74.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. The company had revenue of $29.50 billion for the quarter. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The business’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.02 EPS. Equities research analysts predict that Walgreens Boots Alliance Inc. will post $4.51 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, September 12th. Stockholders of record on Friday, August 19th were paid a dividend of $0.375 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. The ex-dividend date was Wednesday, August 17th. This represents a $1.50 annualized dividend and a dividend yield of 1.86%. Walgreens Boots Alliance’s dividend payout ratio is 51.90%.

Several research analysts have commented on WBA shares. Bank of America Corp. restated a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. Deutsche Bank AG raised their price objective on Walgreens Boots Alliance from $93.00 to $94.00 and gave the stock a “buy” rating in a report on Tuesday, August 30th. Keefe, Bruyette & Woods restated an “underperform” rating on shares of Walgreens Boots Alliance in a report on Friday, July 22nd. Leerink Swann restated an “outperform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. Finally, Credit Suisse Group AG restated an “outperform” rating and set a $95.00 price objective (up from $80.71) on shares of Walgreens Boots Alliance in a report on Thursday, September 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $93.13.

In related news, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total value of $168,150.45. Following the completion of the sale, the director now owns 26,690 shares in the company, valued at $2,171,231.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the firm’s stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $81.03, for a total transaction of $2,406,185.85. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc. (NASDAQ:WBA).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.